Journals / Eurasian Journal of Emergency Medicine / 2020 / Cilt: 19 - Sayı: 3

Diagnostic Value of Adropin Levels in Acute Pulmonary Embolism Patients

Pages
159–165
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The adropin valueswere quite different among the Wells score categories, and the mean adropin levels varied significantly between the PE and control groups.Conclusion: In this study, the plasma adropin levels were significantly high in patients with acute PE and exhibited high positive predictivity,sensitivity, and specificity in detecting PE.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aimed to evaluate the relationship between serum adropin levels in patients with acute pulmonary embolism (PE).Materials and Methods: Patients pre-diagnosed with PE based on computed tomographic pulmonary angiography findings and not fulfillingany of the exclusion criteria were included in the PE group.
📊
Key Findings & Data:Although the adropin values were high in the case of all comorbidities,the values significantly elevated only in patients with hypertension, acute ischaemic stroke, and previous history of PE.
💡
Conclusion & Impact:The adropin valueswere quite different among the Wells score categories, and the mean adropin levels varied significantly between the PE and control groups.Conclusion: In this study, the plasma adropin levels were significantly high in patients with acute PE and exhibited high positive predictivity,sensitivity, and specificity in detecting PE.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This study aimed to evaluate the relationship between serum adropin levels in patients with acute pulmonary embolism (PE).Materials and Methods: Patients pre-diagnosed with PE based on computed tomographic pulmonary angiography findings and not fulfillingany of the exclusion criteria were included in the PE group. An identical number of participants with comorbidities similar to those of the PEgroup were included in the control group. These patientswere selected from those who had been referred to the emergency department andwere not considered to have PE based on clinical symptoms and risk scores.Results: Serum adropin levels were found to be high in the PE group. Although the adropin values were high in the case of all comorbidities,the values significantly elevated only in patients with hypertension, acute ischaemic stroke, and previous history of PE. The adropin valueswere quite different among the Wells score categories, and the mean adropin levels varied significantly between the PE and control groups.Conclusion: In this study, the plasma adropin levels were significantly high in patients with acute PE and exhibited high positive predictivity,sensitivity, and specificity in detecting PE.

🔖

Cite This Article

AYDEMİR, F. H. Y., AYRANCI, M. K., GÜL, M., SÖNMEZ, L. Ö., MEDNİ, M. R. (2022). Diagnostic Value of Adropin Levels in Acute Pulmonary Embolism Patients. Eurasian Journal of Emergency Medicine, Cilt: 19 - Sayı: 3, 159–165. https://ajindex.com/articles/507982

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Smith TP. Pulmonary embolism; what’s wrong with this diagnosis? AJR. 2000;174:1489-97
  2. Guyton AC, Hall JE. Tıbbi Fizyoloji. In: Yüce Yayıncılık, İstanbul, Çavuşoğlu HN, Yeğen BC, Aydın Z, Alican İ, editors
  3. Baskı; 1996;463-9
  4. Riedel M. Venous Tromboembolic Disease, Acute Pulmonary Embolism, Pathophysiology, Clinical Presentation and Diagnosis. Heart. 2001;85:229- 40
  5. Stratmann G, Gregory GA. Neurogenic and humoral vasoconstriction in acute pulmonary thromboembolism Anesth Analg. 2003;97:341‐54
  6. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003;108:2054-9
  7. Endemenn DH, Schriffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983-92
  8. Roquer J, Segura T, Serena J, Castillo J. Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis. 2009;27(Suppl 1):25- 37
  9. Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C, et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med. 2014;52:751-8
  10. Topuz M, Celik A, Aslantas T, Demir AK, Aydin S, Aydin S. Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus. J Investig Med. 2013;61:1161-4
  11. Di Nisio M, Squizzato A, Rutjes AWS, Büller HR, Zwinderman AH, Bossuyt PMM. Diagnostic accuracy of D‐dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007;5:296‐304
  12. Giannitsis E, Müler-Bardoff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation. 2000;102;211-7
  13. Stein BC, Levine RI. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ishemic heart disease. Am Heart J. 1998;135:914-23
  14. Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8:468-81
  15. Kumar KG, Zhang J, Gao S, Rossi J, Mc Guinness OP, Halem HH, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring). 2012;20:1394-402
  16. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary emboli